Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenues:
Revenues	$ 14,255	$ 7,721
Operating costs and expenses:
Research and development	43,833	21,154
Acquired in-process research and development	7,512
Selling, general and administrative	43,394	26,299
Intangible amortization	1,035	992
Total operating costs and expenses	99,160	50,884
Loss from operations	(84,905)	(43,163)
Gain on derivative liabilities	2,200	4,920
Loss on foreign currency exchange	(540)	(147)
Interest expense, net	(2,366)	(6,806)
Gain on marketable investment	94,431
Loss on equity method investments	(419)	(556)
Loss on debt extinguishment, net	(6,111)	(23,645)
Other loss	(78)	(59)
Income (loss) before income tax	2,212	(69,456)
Income tax benefit	(206)	(276)
Net income (loss)	2,418	(69,180)
Net loss attributable to noncontrolling interests	(92)	(3,985)
Net income (loss) attributable to Sorrento	$ 2,510	$ (65,195)
Net income (loss) per share - basic per share attributable to Sorrento	$ 0.01	$ (0.36)
Net income (loss) per share - diluted per share attributable to Sorrento	$ 0.01	$ (0.36)
Weighted-average shares used during period - basic per share attributable to Sorrento	280,604	182,609
Weighted-average shares used during period - diluted per share attributable to Sorrento	297,909	182,609
Product
Revenues:
Revenues	$ 7,023	$ 5,248
Operating costs and expenses:
Cost of products sold and services	852	548
Service
Revenues:
Revenues	7,232	2,473
Operating costs and expenses:
Cost of products sold and services	$ 2,534	$ 1,891